Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Daniel Newman

1PUBLICATIONS
5CO-AUTHORS
Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Aug 14, 2020
Fingolimod inhibits multiple stages of the HIV-1 life cycle.

Rachel S Resop, Rémi Fromentin, Daniel Newman

Pageof 1

Frequent Collaborators

1 joint publications

Rachel S Resop

1 joint publications

Rémi Fromentin

1 joint publications

Michael Bukrinsky

1 joint publications

Nicolas Chomont

1 joint publications

Alberto Bosque

Frequent Collaborators

1 joint publications

Rachel S Resop

1 joint publications

Rémi Fromentin

1 joint publications

Michael Bukrinsky

1 joint publications

Nicolas Chomont

Top Related Videos

A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
07:22

A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion

Published on : Aug 14, 2018

6.8K
See more related videos

Top Related Videos

A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
07:22

A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion

Published on : Aug 14, 2018

6.8K
See more related videos